On Oct. 30, 2023, Aragen, a contract research development and manufacturing organization (CRDMO), announced that it was setting up a new biologics manufacturing facility in Bangalore, India as part of a $30 million investment.
The new 160,000 m2 facility will include process development labs and multiple good manufacturing practice (GMP) suites as well as supporting functions such as quality control labs (analytical and microbiology). The GMP manufacturing suites will be equipped to conduct intensified bioprocessing using single-use bioreactors and will have advanced downstream purification capability, according to a company press release.
